Differentially Expressed Genes in Bullous Pemphigoid Immune-Related Adverse Event (BP-irAE) from Immune Checkpoint Inhibitor Therapy: Implications in the Immunopathogenic Mechanisms Driving BP-irAE Compared to De Novo BP Control-MedSci.cn

Differentially Expressed Genes in Bullous Pemphigoid Immune-Related Adverse Event (BP-irAE) from Immune Checkpoint Inhibitor Therapy: Implications in the Immunopathogenic Mechanisms Driving BP-irAE Compared to De Novo BP Control

Marques-Piubelli, M; Tetzlaff, M; Muhlbauer, A; Wang, J; Nelson, K; Nagarajan, P; Aung, P; Torres-Cabala, C; Pacha, O; Prieto, V; Subramanya, S; Wistuba, I; Curry, J

LABORATORY INVESTIGATION, 2020; 100 (SUPPL 1): 478

科室
- - 订阅+
  - 更多科室
工具
服务